Evan L. Wasoff

Insider Reports History

Location
Nederland, CO
Signature
Evan L. Wasoff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Evan L. Wasoff:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEXIEN BIOPHARMA, INC. Chief Financial Officer Common stock 6,500,000 23 May 2024 Direct
NEXIEN BIOPHARMA, INC. Chief Financial Officer Options to purchase common stock (right to buy) 200,000 23 May 2024 Direct

Insider Reports Filed by Evan L. Wasoff

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NXEN NEXIEN BIOPHARMA, INC. 23 May 2024 1 $0 4 Chief Financial Officer 28 May 2024, 11:57
NXEN NEXIEN BIOPHARMA, INC. 31 Oct 2023 1 $0 4 Chief Financial Officer 02 Nov 2023, 16:02
NXEN NEXIEN BIOPHARMA, INC. 25 Jul 2023 1 $0 4 Chief Financial Officer 31 Jul 2023, 15:35
NXEN NEXIEN BIOPHARMA, INC. 01 Apr 2023 1 $0 4 Chief Financial Officer 19 Apr 2023, 18:48
NXEN NEXIEN BIOPHARMA, INC. 17 Jan 2023 1 $0 4 Chief Financial Officer 17 Jan 2023, 12:23
NXEN NEXIEN BIOPHARMA, INC. 17 Oct 2022 1 $0 4 Chief Financial Officer 18 Oct 2022, 11:04
NXEN NEXIEN BIOPHARMA, INC. 20 Apr 2022 2 $0 4 Chief Financial Officer 14 Sep 2022, 17:42
NXEN NEXIEN BIOPHARMA, INC. 27 Jan 2022 1 $0 4 Chief Financial Officer 31 Jan 2022, 14:55
NXEN NEXIEN BIOPHARMA, INC. 29 Nov 2021 1 $0 4 Chief Financial Officer 29 Nov 2021, 11:20